300 billion Chinese medicine market "big shuffle" will accelerate!

"Pharmaceutical Network Industry Dynamics" Chinese traditional medicine is a part of Traditional Chinese medicine, is based on Chinese medicine as raw materials, under the guidance of chinese medicine theory, according to the prescribed prescription and preparation process to process it into a certain dosage form of Chinese medicine products.
has always occupied an important position in China's pharmaceutical market.
Recently, the State Health Insurance Administration revealed that the relevant departments had held a symposium in mid-July to listen to expert opinions and suggestions on the centralized procurement of biological products (including insulin) and Chinese medicine, to study and improve procurement policies in related fields, and to promote the reform of procurement methods.
To this, the industry believes that China's further expansion of centralized procurement scope of the signal has been very clear, although the Chinese medicine market compared with chemical drugs have its particularity, but Chinese medicine into the collection and price reduction, has obviously become the trend.
future, the market of Chinese medicine exceeding 300 billion yuan may officially enter the "shuffle" stage with the volume of procurement, and the performance of Chinese medicine enterprises will also be affected.
fact, regardless of whether the national harvest will be incorporated into Chinese medicine, the local has been the first to try.
In June this year, Jinhua City, Zhejiang Province, issued the second batch of drug belt procurement announcement (a total of 274 product regulations) into a total of 180 Chinese medicine, of which 33 are low-cost drugs, including oral, injections, patches and other dosage forms;
In late July, Qinghai Province's centralized procurement network of pharmaceutical and medical supplies also released qinghai Province's public medical institutions drug belt procurement bargaining varieties catalog and Qinghai Province public hospital drug belt procurement of the results of the proposed selection, the results show that thrombosis injections, injection of blood plugs (freeze-dried), Magpie flat injections, blood plugs and other large varieties of drugs into the centralized belt procurement of drugs catalog.
industry said that the experience of several batches of chemical drugs, once the collection policy is formally implemented, a significant reduction in drug prices will be inevitable.
experts, once the selected varieties appear in the country to low prices, it will lead to a series of price cuts in the market, or will make the development of Chinese medicine enterprises more difficult.
addition, because of the difference between chemical drugs, traditional Chinese medicine in the safety and effectiveness of the lack of data, product regulations are more complex.
if The Chinese medicine to carry out a wide range of harvesting, the industry has been calling for the Chinese medicine market after the evaluation policy may be accelerated.
more complex in the collection of Chinese medicine, more stringent standards may be introduced in the future.
In short, the National Health Insurance Administration has released a signal for the collection of Chinese medicine, the follow-up collection covers the category or will be further expanded in the background, the need for innovative research and development of pharmaceutical companies will be further highlighted.
At the same time, as more and more varieties are included in the scope of collection, there may be clinical substitution problems between collection varieties, some varieties that do not adapt to clinical needs may also be phased out of the collection queue, and small and medium-sized enterprises may also be affected by the out, industry concentration further improved.
In the depth of medical reform is imperative, the industry believes that Chinese medicine enterprises need to have the determination of strong men to break their wrists, only to accelerate the transformation into an enterprise with research and development innovation ability, fine operation can achieve the future.
.